当前位置:首页 - 行情中心 - 微芯生物(688321) - 财务分析

微芯生物

(688321)

  

流通市值:124.34亿  总市值:124.34亿
流通股本:4.08亿   总股本:4.08亿

微芯生物(688321)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.71亿元,每股收益0.17元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益165588.39万元,未分配利润7377.87万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产363319.28万元,负债197730.89万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入674,157,709.09406,598,517.7162,263,736.11657,949,379.86
营业总成本597,523,641.23376,480,827.83181,685,156.93735,520,875.8
其他经营收益
营业利润70,399,030.328,120,919.48-18,597,145.82-178,502,793.33
利润总额70,314,760.3528,065,637.36-18,596,691.33-96,711,888.26
净利润70,767,514.8529,592,228.83-19,154,672.71-114,570,600.33
每股收益
其他综合收益-516,553.25-209,350.4-81,678.3754,998.1
综合收益总额70,250,961.629,382,878.43-19,236,351.01-113,815,602.23
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,338,524,487.151,246,399,390.821,134,827,622.721,083,471,551.64
非流动资产:
非流动资产合计2,294,668,340.762,188,403,802.32,176,875,505.652,167,427,506.54
资产总计3,633,192,827.913,434,803,193.123,311,703,128.373,250,899,058.18
流动负债:
流动负债合计716,038,451.58650,505,729.15481,443,280.53451,311,494.66
非流动负债:
非流动负债合计1,261,270,465.271,169,543,706.341,268,397,450.081,218,488,814.75
负债合计1,977,308,916.851,820,049,435.491,749,840,730.611,669,800,309.41
所有者权益(或股东权益):
归属于母公司股东权益合计1,655,883,911.061,614,753,757.631,561,862,397.761,581,098,748.77
股东权益合计1,655,883,911.061,614,753,757.631,561,862,397.761,581,098,748.77
负债和股东权益合计3,633,192,827.913,434,803,193.123,311,703,128.373,250,899,058.18
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计637,831,624.93433,184,403.84214,206,916.99747,991,861.67
经营活动现金流出小计577,909,550.15371,125,906.32194,227,068.7671,863,584.36
经营活动产生的现金流量净额59,922,074.7862,058,497.5219,979,848.2976,128,277.31
投资活动产生的现金流量:
投资活动现金流入小计1,110,864,563.78696,041,367.29290,169,761.161,376,083,402.57
投资活动现金流出小计1,259,808,047.82745,964,987.8347,281,222.091,672,117,566.25
投资活动产生的现金流量净额-148,943,484.04-49,923,620.51-57,111,460.93-296,034,163.68
筹资活动产生的现金流量:
筹资活动现金流入小计401,885,265197,000,000125,000,000408,185,670
筹资活动现金流出小计237,912,188.88102,310,830.1766,437,641.14232,822,847.19
筹资活动产生的现金流量净额163,973,076.1294,689,169.8358,562,358.86175,362,822.81
汇率变动对现金及现金等价物的影响-1,729,409.36-77,413.06-143,302.02394,133.86
现金及现金等价物净增加额73,222,257.5106,746,633.7821,287,444.2-44,148,929.7
期末现金及现金等价物余额295,762,666.36329,287,042.64243,827,853.06222,540,408.86
补充资料:
现金及现金等价物的净增加额-106,746,633.78--44,148,929.7
最新报告期:2025-08-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
太平洋张懿,谭紫媚0.200.260.362025-08-30
财通证券华挺0.140.420.822025-08-26
TOP↑